What factors affect the sufficient dose of paroxetine?

antidepressant Paxil® antidepressant drugs is a branded form of paroxetine hydrochloride, which is commonly used to treat depression. New research has shown that paroxetine may be effective in the treatment of obsessive compulsive disorders and a number of anxiety disorders. When determining the appropriate dose of paroxetine for management, adjustments that correspond to the condition, as well as age, liver health and kidney function in the patient must be made.

According to the manufacturer, the standard dose for adult paroxetin is 20 mg from tablets with immediate release of orally. Drugs are generally administered in the morning to reduce the occurrence of side effects of paroxetine, such as sleep disorder. The next dose of maintenance between 20 and 50 mg may be given in the morning if necessary. The standard dose of paroxetin can be re -evaluated every week, although it may take four to six weeks after the start of treatment to create a significance signal to reduce symptoms.

Recommended treatment protocol in patients suffering from post -traumatic stress disorder, generalized anxiety disorder or obedAntenna compulsive disorder is the same as in patients suffering from depression. However, daily doses should not exceed 60 mg including maintenance doses. The same instructions also apply to a reassessment of the dose.

However, the recommendations for the treatment of panic disorder are somewhat different. Instead of 20 mg recommended for other conditions, the initial dose of paroxetin 10 mg should be administered. If a dose of up to 40 mg is beneficial, up to 40 mg can still be given, although it is important to administer the lowest possible effective dose to minimize the side effects and the potential of dependence.

patients suffering from reduced liver function should only be administered 10 mg. If the results are not ohieved, the daily dose of paroxetin can be increased by 10 mg every seven days up to a maximum dose of 40 mg. Patients with a serious loss of kidney function - CRCL levels 25 ml/min or less - should be governed by the same regime as in patients with reduced liver function.

Also sold as sereupin®, seroxat® and AROPAX®, a paroxetine drug is a member of the selective class inhibition of serotonin reury (SSRI), which was subject to considerable controversy. Between 2000 and 2010, the accusation of hiding evidence concerning their potential for addiction, weight gain, suicidal thoughts and questions about their effectiveness Versus placebos were fought. Since 2010, paroxetin has remained the sixth most popular drugs prescribed in the United States for the treatment of depression and exceeds more dangerous tricyclic drugs replaced by IT and other SSRI drugs.